Founded in 2005, Coben Group was designed and built according to GMP standard with a total area of 100,000M2, a member of ZJMI Group-Global Fortune 500, Ranked No.270 in 2018.
Coben is specialized in developing and manufacturing of APIs and intermediates for anti-virus drugs(HIV,HBV,HCV). Main products include:Lamivudine, Tenofovir, Zidovudine, Emtricitabine, Telbivudine, Oseltamivir phosphate, Gemcitabine, Sofosbuvir , Aba...
Founded in 2005, Coben Group was designed and built according to GMP standard with a total area of 100,000M2, a member of ZJMI Group-Global Fortune 500, Ranked No.270 in 2018.
Coben is specialized in developing and manufacturing of APIs and intermediates for anti-virus drugs(HIV,HBV,HCV). Main products include:Lamivudine, Tenofovir, Zidovudine, Emtricitabine, Telbivudine, Oseltamivir phosphate, Gemcitabine, Sofosbuvir , Abacavir and their intermediates.
Coben is hi-tech enterprises, owning provincial R&D center. Most of the products are self-developed. We hold national and international patents for many product.
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.